Blood Genomics Identifies Three Subtypes of Systemic Lupus Erythematosus: “IFN-High,” “NE-High,” and “Mixed”
Purpose. Systemic lupus erythematosus (SLE) is a systemic and multifactorial autoimmune disease, and its diverse clinical manifestations affect molecular diagnosis and drug benefits. Our study was aimed at defining the SLE subtypes based on blood transcriptome data, analyzing functional patterns, an...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2021/6660164 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832546191657664512 |
---|---|
author | Mintian Cui Taotao Li Xinwei Yan Chao Wang Qi Shen Hongbiao Ren Liangshuang Li Ruijie Zhang |
author_facet | Mintian Cui Taotao Li Xinwei Yan Chao Wang Qi Shen Hongbiao Ren Liangshuang Li Ruijie Zhang |
author_sort | Mintian Cui |
collection | DOAJ |
description | Purpose. Systemic lupus erythematosus (SLE) is a systemic and multifactorial autoimmune disease, and its diverse clinical manifestations affect molecular diagnosis and drug benefits. Our study was aimed at defining the SLE subtypes based on blood transcriptome data, analyzing functional patterns, and elucidating drug benefits. Methods. Three data sets were used in this paper that were collected from the Gene Expression Omnibus (GEO) database, which contained two published data sets of pediatric and adult SLE patients (GSE65391, GSE49454) and public longitudinal data (GSE72754) from a cohort of SLE patients treated with IFN-α Kinoid (IFN-K). Based on disease activity scores and gene expression data, we defined a global SLE signature and merged three clustering algorithms to develop a single-sample subtype classifier (SSC). Systematic analysis of coexpression networks based on modules revealed the molecular mechanism for each subtype. Results. We identified 92 genes as a signature of the SLE subtypes and three intrinsic subsets (“IFN-high,” “NE-high,” and “mixed”), which varied in disease severity. We speculated that IFN-high might be due to the overproduction of interferons (IFNs) caused by viral infection, leading to the formation of autoantibodies. NE-high might primarily result from bacterial and fungal infections that stimulated neutrophils (NE) to produce neutrophil extracellular traps (NETs) and induced individual autoimmune responses. The mixed type contained both of these molecular mechanisms and showed an intrinsic connection. Conclusions. Our research results indicated that identifying the molecular mechanism associated with different SLE subtypes would benefit the molecular diagnosis and stratified therapy. Moreover, repositioning of IFN-K based on subtypes also revealed an improved therapeutic effect, providing a new direction for disease treatment and drug development. |
format | Article |
id | doaj-art-45d5641db43f4fec91a55ae1aa201e42 |
institution | Kabale University |
issn | 0962-9351 1466-1861 |
language | English |
publishDate | 2021-01-01 |
publisher | Wiley |
record_format | Article |
series | Mediators of Inflammation |
spelling | doaj-art-45d5641db43f4fec91a55ae1aa201e422025-02-03T07:23:31ZengWileyMediators of Inflammation0962-93511466-18612021-01-01202110.1155/2021/66601646660164Blood Genomics Identifies Three Subtypes of Systemic Lupus Erythematosus: “IFN-High,” “NE-High,” and “Mixed”Mintian Cui0Taotao Li1Xinwei Yan2Chao Wang3Qi Shen4Hongbiao Ren5Liangshuang Li6Ruijie Zhang7College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150086, ChinaCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150086, ChinaCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150086, ChinaCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150086, ChinaCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150086, ChinaCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150086, ChinaCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150086, ChinaCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150086, ChinaPurpose. Systemic lupus erythematosus (SLE) is a systemic and multifactorial autoimmune disease, and its diverse clinical manifestations affect molecular diagnosis and drug benefits. Our study was aimed at defining the SLE subtypes based on blood transcriptome data, analyzing functional patterns, and elucidating drug benefits. Methods. Three data sets were used in this paper that were collected from the Gene Expression Omnibus (GEO) database, which contained two published data sets of pediatric and adult SLE patients (GSE65391, GSE49454) and public longitudinal data (GSE72754) from a cohort of SLE patients treated with IFN-α Kinoid (IFN-K). Based on disease activity scores and gene expression data, we defined a global SLE signature and merged three clustering algorithms to develop a single-sample subtype classifier (SSC). Systematic analysis of coexpression networks based on modules revealed the molecular mechanism for each subtype. Results. We identified 92 genes as a signature of the SLE subtypes and three intrinsic subsets (“IFN-high,” “NE-high,” and “mixed”), which varied in disease severity. We speculated that IFN-high might be due to the overproduction of interferons (IFNs) caused by viral infection, leading to the formation of autoantibodies. NE-high might primarily result from bacterial and fungal infections that stimulated neutrophils (NE) to produce neutrophil extracellular traps (NETs) and induced individual autoimmune responses. The mixed type contained both of these molecular mechanisms and showed an intrinsic connection. Conclusions. Our research results indicated that identifying the molecular mechanism associated with different SLE subtypes would benefit the molecular diagnosis and stratified therapy. Moreover, repositioning of IFN-K based on subtypes also revealed an improved therapeutic effect, providing a new direction for disease treatment and drug development.http://dx.doi.org/10.1155/2021/6660164 |
spellingShingle | Mintian Cui Taotao Li Xinwei Yan Chao Wang Qi Shen Hongbiao Ren Liangshuang Li Ruijie Zhang Blood Genomics Identifies Three Subtypes of Systemic Lupus Erythematosus: “IFN-High,” “NE-High,” and “Mixed” Mediators of Inflammation |
title | Blood Genomics Identifies Three Subtypes of Systemic Lupus Erythematosus: “IFN-High,” “NE-High,” and “Mixed” |
title_full | Blood Genomics Identifies Three Subtypes of Systemic Lupus Erythematosus: “IFN-High,” “NE-High,” and “Mixed” |
title_fullStr | Blood Genomics Identifies Three Subtypes of Systemic Lupus Erythematosus: “IFN-High,” “NE-High,” and “Mixed” |
title_full_unstemmed | Blood Genomics Identifies Three Subtypes of Systemic Lupus Erythematosus: “IFN-High,” “NE-High,” and “Mixed” |
title_short | Blood Genomics Identifies Three Subtypes of Systemic Lupus Erythematosus: “IFN-High,” “NE-High,” and “Mixed” |
title_sort | blood genomics identifies three subtypes of systemic lupus erythematosus ifn high ne high and mixed |
url | http://dx.doi.org/10.1155/2021/6660164 |
work_keys_str_mv | AT mintiancui bloodgenomicsidentifiesthreesubtypesofsystemiclupuserythematosusifnhighnehighandmixed AT taotaoli bloodgenomicsidentifiesthreesubtypesofsystemiclupuserythematosusifnhighnehighandmixed AT xinweiyan bloodgenomicsidentifiesthreesubtypesofsystemiclupuserythematosusifnhighnehighandmixed AT chaowang bloodgenomicsidentifiesthreesubtypesofsystemiclupuserythematosusifnhighnehighandmixed AT qishen bloodgenomicsidentifiesthreesubtypesofsystemiclupuserythematosusifnhighnehighandmixed AT hongbiaoren bloodgenomicsidentifiesthreesubtypesofsystemiclupuserythematosusifnhighnehighandmixed AT liangshuangli bloodgenomicsidentifiesthreesubtypesofsystemiclupuserythematosusifnhighnehighandmixed AT ruijiezhang bloodgenomicsidentifiesthreesubtypesofsystemiclupuserythematosusifnhighnehighandmixed |